| 查看: 5304 | 回復: 12 | ||
| 【懸賞金幣】回答本帖問題,作者WORKDAY將贈送您 5 個金幣 | ||
[求助]
審稿人意見major revision,改后重投悲劇,如何申訴? 已有7人參與
|
||
|
各位同僚,在投稿BMC nephrology 之后兩位審稿人給的意見都是major revision,后責編回信reject但是提出:如果可以point by point回復審稿意見,歡迎我們resubmit a new manuscript,按照責編的要求一一修改后resubmit,可是一個月后責編回信拒掉了,也沒送審。我勒個去,這種情況有經驗的同志指導一下,我是該申訴呢還是該申訴呢?責編為啥沒送審直接拒掉了?下附信件內容: 第一次責編回信的內容:Peer review of your manuscript is now complete and, based on the reports, I am sorry to say that we cannot consider the manuscript for publication at this time. We think it may be possible to revise your manuscript to address these comments but that this would require longer than our standard revision period. However, we are willing to consider your manuscript further once all the concerns have been addressed. Therefore, if you are able to address all of these concerns, please do submit a new manuscript to BMC Nephrology. If you are able to do this, a full covering letter, explaining the revisions made, should accompany the submission. Their reports, together with any other comments, are below. Please also take a moment to check our website at https://www.editorialmanager.com/bnep/ for any additional comments that were saved as attachments. Please note that as BMC Nephrology has a policy of open peer review, you will be able to see the names of the reviewers. If you can address all of these concerns raised, please do submit a new manuscript to https://www.editorialmanager.com/bnep/. We request that a point-by-point response letter accompanies your revised manuscript. This letter must provide a detailed response to each reviewer/editorial point raised, describing what amendments have been made to the manuscript text and where these can be found (e.g. Methods section, line 12, page 5). Please also ensure that all changes to the manuscript are indicated in the text by highlighting or using track changes. If you disagree with any comments raised, please provide a detailed rebuttal to help explain and justify your decision. Please note that this decision applies across the BMC-series journals (https://www.biomedcentral.com/authors/bmcseries#journallist). Therefore, if you were to submit your revised manuscript to another journal within the BMC series, your submission should also be accompanied by a full covering letter. I wish you every success with your research and hope that you will consider us again in the f 第二次責編回信內容: Editor\'s comments: The paper is useful but not of practical assistance. A sudden progression of renal dysfunction in patients with CKD already on a nephrotoxic chronic medication will always require a search for any reversible etiology. |
至尊木蟲 (文壇精英)
|
本帖內容被屏蔽 |
木蟲 (小有名氣)

木蟲 (正式寫手)
木蟲 (著名寫手)
金蟲 (小有名氣)
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 279分求調劑 一志愿211 +14 | chaojifeixia 2026-03-19 | 16/800 |
|
|---|---|---|---|---|
|
[考研] 一志愿北京化工大學 070300 學碩 336分 求調劑 +5 | vv迷 2026-03-22 | 5/250 |
|
|
[考研]
|
2117205181 2026-03-21 | 8/400 |
|
|
[考研] 311求調劑 +6 | 冬十三 2026-03-18 | 6/300 |
|
|
[考研] 生物學調劑 +5 | Surekei 2026-03-21 | 5/250 |
|
|
[考研] 303求調劑 +5 | 安憶靈 2026-03-22 | 6/300 |
|
|
[考博] 招收博士1-2人 +3 | QGZDSYS 2026-03-18 | 4/200 |
|
|
[考研]
|
Grand777 2026-03-21 | 3/150 |
|
|
[考研] 材料與化工(0856)304求B區(qū)調劑 +3 | 邱gl 2026-03-20 | 7/350 |
|
|
[考研] 材料工程專碩 348分求調劑 +3 | 冬辭. 2026-03-17 | 5/250 |
|
|
[考研] 278求調劑 +9 | 煙火先于春 2026-03-17 | 9/450 |
|
|
[考研] 265求調劑 +12 | 梁梁校校 2026-03-19 | 14/700 |
|
|
[考研] 材料學學碩080502 337求調劑-一志愿華中科技大學 +4 | 順順順mr 2026-03-18 | 5/250 |
|
|
[考研] 274求調劑 +10 | S.H1 2026-03-18 | 10/500 |
|
|
[考研] 294求調劑材料與化工專碩 +15 | 陌の森林 2026-03-18 | 15/750 |
|
|
[考研] 0817 化學工程 299分求調劑 有科研經歷 有二區(qū)文章 +22 | rare12345 2026-03-18 | 22/1100 |
|
|
[考研] 261求B區(qū)調劑,科研經歷豐富 +3 | 牛奶很忙 2026-03-20 | 4/200 |
|
|
[論文投稿]
申請回稿延期一個月,編輯同意了。但系統(tǒng)上的時間沒變,給編輯又寫郵件了,沒回復
10+3
|
wangf9518 2026-03-17 | 4/200 |
|
|
[考研] 材料學碩318求調劑 +5 | February_Feb 2026-03-19 | 5/250 |
|
|
[考研] 材料工程專碩調劑 +5 | 204818@lcx 2026-03-17 | 6/300 |
|